muscarinic acetylcholine receptor

M1-type muscarinic acetylcholine receptors play a role in cognitive processing.

We had of course already found a transient increase in the muscarinic acetylcholine receptor.

Its mechanism of action involves blocking the muscarinic acetylcholine receptors.

Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.

Its pharmacological effects are due to binding to muscarinic acetylcholine receptors.

Cetirizine does not block the action of the muscarinic acetylcholine receptors, even though these side effects can occur in some patients.

It is a nonselective agonist of the muscarinic acetylcholine receptor.

It is well known for being an irreversible inhibitor of the muscarinic acetylcholine receptor.

It was also one of the tools in characterization of the muscarinic acetylcholine receptor.

Muscarinic acetylcholine receptors possess a regulatory effect on dopaminergic neurotransmission.

Epibatidine can also bind to muscarinic acetylcholine receptors as an antagonist.

Muscarinic acetylcholine receptors can be blocked by the drugs atropine and scopolamine.

It does not bind to muscarinic acetylcholine receptors.

Muscarinic acetylcholine receptors respond to this release mostly by an increase in cell membrane K+ conductance.

Imipramine is an antagonist at M muscarinic acetylcholine receptors (see external links).

Antimuscarinic agents operate on the muscarinic acetylcholine receptors.

Aceclidine acts as a muscarinic acetylcholine receptor agonist.

Hyoscyamine is an antagonist of muscarinic acetylcholine receptors (antimuscarinic).

Atropine, an antagonist to muscarinic acetylcholine receptors, is given to treat the physiological symptoms of poisoning.

Muscarinic acetylcholine receptor M3.

Darifenacin works by blocking the M muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions.

The upstream M1 muscarinic acetylcholine receptor binds to G-class G proteins.

Muscarinic acetylcholine receptor M3 has been shown to interact with Arf6 and ARF1.

Anticholinergics such as atropine, hyoscyamine, and scopolamine antagonize the muscarinic acetylcholine receptors in the eye.

Muscarine mimics the action of the neurotransmitter acetylcholine by binding muscarinic acetylcholine receptors.